Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 2
1995 3
1996 1
1997 2
1998 17
1999 49
2000 61
2001 165
2002 295
2003 356
2004 495
2005 599
2006 610
2007 725
2008 710
2009 684
2010 716
2011 672
2012 720
2013 727
2014 729
2015 672
2016 722
2017 683
2018 651
2019 628
2020 689
2021 615
2022 553
2023 461
2024 136

Text availability

Article attribute

Article type

Publication date

Search Results

12,317 results

Results by year

Filters applied: . Clear all
Page 1
Infliximab-Related Infusion Reactions: Systematic Review.
Lichtenstein L, Ron Y, Kivity S, Ben-Horin S, Israeli E, Fraser GM, Dotan I, Chowers Y, Confino-Cohen R, Weiss B. Lichtenstein L, et al. J Crohns Colitis. 2015 Sep;9(9):806-15. doi: 10.1093/ecco-jcc/jjv096. Epub 2015 Jun 19. J Crohns Colitis. 2015. PMID: 26092578 Free PMC article. Review.
Psoriasis.
Greb JE, Goldminz AM, Elder JT, Lebwohl MG, Gladman DD, Wu JJ, Mehta NN, Finlay AY, Gottlieb AB. Greb JE, et al. Nat Rev Dis Primers. 2016 Nov 24;2:16082. doi: 10.1038/nrdp.2016.82. Nat Rev Dis Primers. 2016. PMID: 27883001 Review.
Effect of Therapeutic Drug Monitoring vs Standard Therapy During Maintenance Infliximab Therapy on Disease Control in Patients With Immune-Mediated Inflammatory Diseases: A Randomized Clinical Trial.
Syversen SW, Jørgensen KK, Goll GL, Brun MK, Sandanger Ø, Bjørlykke KH, Sexton J, Olsen IC, Gehin JE, Warren DJ, Klaasen RA, Noraberg G, Bruun TJ, Dotterud CK, Ljoså MKA, Haugen AJ, Njålla RJ, Zettel C, Ystrøm CM, Bragnes YH, Skorpe S, Thune T, Seeberg KA, Michelsen B, Blomgren IM, Strand EK, Mielnik P, Torp R, Mørk C, Kvien TK, Jahnsen J, Bolstad N, Haavardsholm EA. Syversen SW, et al. JAMA. 2021 Dec 21;326(23):2375-2384. doi: 10.1001/jama.2021.21316. JAMA. 2021. PMID: 34932077 Free PMC article. Clinical Trial.
SB2: An Infliximab Biosimilar.
Lamb YN, Scott LJ, Deeks ED. Lamb YN, et al. BioDrugs. 2017 Oct;31(5):461-464. doi: 10.1007/s40259-017-0240-7. BioDrugs. 2017. PMID: 28803431 Review.
[Infliximab].
Goujon C, Bachelez H; Groupe de recherche sur le psoriasis de la Société française de dermatologie. Goujon C, et al. Ann Dermatol Venereol. 2019 Jun-Jul;146(6-7):483-486. doi: 10.1016/j.annder.2019.04.013. Epub 2019 Jun 20. Ann Dermatol Venereol. 2019. PMID: 31230775 French. No abstract available.
Infliximab for medical induction of remission in Crohn's disease.
Gordon M, Sinopoulou V, Akobeng AK, Radford SJ, Eldragini MEAA, Darie AM, Moran GW. Gordon M, et al. Cochrane Database Syst Rev. 2023 Nov 20;11(11):CD012623. doi: 10.1002/14651858.CD012623.pub2. Cochrane Database Syst Rev. 2023. PMID: 37982428 Free PMC article.
12,317 results
You have reached the last available page of results. Please see the User Guide for more information.